April, 2020: NeuroGT was awarded two-year Phase I STTR grant from the NIH/NINDS ($682,248)

www.NeuroGT.com > Blog Large Image > News & Updates > April, 2020: NeuroGT was awarded two-year Phase I STTR grant from the NIH/NINDS ($682,248)
21
Apr
Date 21 April 2024
Author neurogt.com Tags

April, 2020: NeuroGT was awarded two-year Phase I STTR grant from the NIH/NINDS ($682,248)

April, 2020: NeuroGT was awarded two-year Phase I STTR grant from the NIH/NINDS ($682,248), supporting further development of NeuroGT’s gene therapy product (NGT-104) for treating Sanfilippo syndrome B (MPS IIIB), towards clinical application and commercialization.

0 Comments Author neurogt.com

Leave a Reply

Your email address will not be published.

This field is required.

You may use these <abbr title="HyperText Markup Language">html</abbr> tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

*This field is required.